Latest Asx Continuous Disclosure News

INOVIQ Limited clarifies recent share price movements, confirming no undisclosed material information while highlighting an imminent ASCO presentation and provisional patent application tied to its EXO-OC ovarian cancer test.

Axel REE Limited has responded to ASX Compliance queries confirming the timely disclosure of its latest rare earth element drilling results at the Poços de Caldas Caldera, emphasizing the incremental nature of the findings and ongoing compliance with listing rules.

Nufarm Limited confirms its half-year earnings align closely with analyst expectations despite a late-stage $16 million inventory valuation adjustment. The company maintains compliance with ASX disclosure rules amid market scrutiny.

Fintech Chain Limited has applied to delist from the ASX, citing low valuation, poor liquidity, and high costs, aiming to unlock growth capital in China and the US.

Infomedia Ltd has responded to an ASX price query following a sharp share price decline and increased trading volume, denying any undisclosed material information. The company pointed to the recent closure of Celeste Funds, a known shareholder, as a potential external factor influencing market activity.

Liontown Resources has responded to an ASX query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Resource Mining Corporation Limited (RMI) has responded to a sharp surge in its share price and trading volume, denying any undisclosed material information while pointing to ongoing copper-gold exploration activities at its Mpanda Project in Tanzania.

EDU Holdings Limited plans to voluntarily delist from the ASX, citing low share liquidity and regulatory uncertainty in the international student market. The company proposes a substantial buy-back offer to provide shareholders with an exit opportunity ahead of delisting.

Mayne Pharma has addressed a sharp share price decline following the public release of an FDA Untitled Letter, confirming no undisclosed material information and reaffirming compliance with ASX rules.

Nimy Resources has clarified that no undisclosed information explains its recent share price jump, pointing instead to ongoing drilling and positive media coverage about a gallium discovery.

Holista Colltech Limited has responded to an ASX price query regarding recent unusual trading activity, confirming no undisclosed material information exists to explain the surge.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.